{"id":288,"date":"2023-09-25T15:34:48","date_gmt":"2023-09-25T08:34:48","guid":{"rendered":"https:\/\/score.ccme.or.th\/ccme-wp\/?p=288"},"modified":"2023-09-27T14:00:22","modified_gmt":"2023-09-27T07:00:22","slug":"hibor","status":"publish","type":"post","link":"https:\/\/score.ccme.or.th\/ccme-wp\/2023\/09\/25\/hibor\/","title":{"rendered":"Hibor"},"content":{"rendered":"\n<figure class=\"wp-block-image aligncenter size-large is-resized\"><img fetchpriority=\"high\" decoding=\"async\" width=\"500\" height=\"500\" data-attachment-id=\"187\" data-permalink=\"https:\/\/score.ccme.or.th\/ccme-wp\/20230327_hibor-removebg-preview\/\" data-orig-file=\"https:\/\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/09\/20230327_hibor-removebg-preview.png\" data-orig-size=\"500,500\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"20230327_hibor-removebg-preview\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/09\/20230327_hibor-removebg-preview.png\" data-large-file=\"https:\/\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/09\/20230327_hibor-removebg-preview.png\" src=\"https:\/\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/09\/20230327_hibor-removebg-preview.png?w=500\" alt=\"\" class=\"wp-image-187\" style=\"width:448px;height:auto\" \/><\/figure>\n\n\n\n<p><strong>Indication<\/strong><\/p>\n\n\n\n<p><strong>Hibor 2500 I.U. &amp; 3500 I.U.&nbsp;<\/strong>Prevention of venous thromboembolism (VTE)<\/p>\n\n\n\n<p><strong>Hibor 5000 I.U., 7500 I.U., 10000 I.U.&nbsp;<\/strong>Treatment of venous thromboembolism (VTE)<\/p>\n\n\n\n<p><strong>Qualitative Quantitative Composition<\/strong><\/p>\n\n\n\n<p>Bemiparin sodium 2,500 IU (anti-Xa)\/0.2 ml<\/p>\n\n\n\n<p>Bemiparin sodium 3500 IU\/0.2 ml<\/p>\n\n\n\n<p>Bemiparin sodium 5,000 IU (anti-Xa)\/0.2 ml<\/p>\n\n\n\n<p>Bemiparin sodium 7,500 IU (anti-Xa)\/0.3 ml<\/p>\n\n\n\n<p>Bemiparin sodium 10,000 IU (anti-Xa)\/0.4 ml<\/p>\n\n\n\n<p><strong>Pharmaceutical Dose Form<\/strong><\/p>\n\n\n\n<p>Solution for injection in pre-filled syringe<\/p>\n\n\n\n<p><strong>Dose And Administration<\/strong><\/p>\n\n\n\n<p><strong>General surgery with moderate risk of venous thromboembolism:<\/strong><\/p>\n\n\n\n<p>On the day of the surgical procedure, 2,500 IU anti-Xa is to be administered by subcutaneous route (sc), 2 hours before or 6 hours after surgery.<\/p>\n\n\n\n<p>On subsequent days, 2,500 IU anti-Xa sc is to be administered every 24 hours.<\/p>\n\n\n\n<p><strong>Prevention of thromboembolic disease in non-surgical patients:<\/strong><\/p>\n\n\n\n<p>The recommended posology of bemiparin is 2.500 IU\/day or 3.500 IU\/day by sc route, according to whether the set of risk factors of the patient defines as mild or high thromboembolic risk.<\/p>\n\n\n\n<p><strong>Prevention of clotting in the extracorporeal circulation circuit during haemodialysis<\/strong><\/p>\n\n\n\n<p>For patients undergoing repeated haemodialysis sessions of no longer than 4 hours in duration and with no risk of bleeding, the prevention of clotting in the extracorporeal circulation circuit is obtained by injecting a single dose in the form of bolus into the arterial line at the beginning of the dialysis session.<\/p>\n\n\n\n<p>For patients weighing less than 60 kg, the dose to be administered will be 2,500 IU, whereas for patients weighing more than 60 kg, the dose to be administered will be 3,500 IU.<\/p>\n\n\n\n<p><strong>Treatment of venous thromboembolism (VTE)<\/strong><\/p>\n\n\n\n<p>HIBOR should be administered by subcutaneous route at the fixed dose of 115 IU anti-Xa\/kg weight\/day, during 7 \u00b1 2 days as a general rule. This daily dose generally correspondes, depending on the body weight, to the ranges: &lt;50 kg, 0.2 ml (5,000 IU anti-Xa); 50-70 kg, 0.3 ml (7,500 IU anti-Xa) ; 70-100 kg, 0.4 ml (10,000 IU anti-Xa) and 100-120 kg, 0.5 ml (12,500 IU anti-Xa). In patients of &gt; 120 kg of weight, the dose to be administered must be adjusted to the weight, at a rate of 115 IU anti-Xa\/kg\/day.<\/p>\n\n\n\n<p><strong>Contraindications<\/strong><\/p>\n\n\n\n<p>Hypersensitivity to bemiparin sodium, heparin or substances of porcine origin.<\/p>\n\n\n\n<p>History of confirmed or suspected immunologically mediated heparin induced thrombocytopenia (HIT).<\/p>\n\n\n\n<p>Active haemorrhage or increased risk of bleeding due to impairment of haemostasis.<\/p>\n\n\n\n<p>Severe impairment of liver or pancreatic function.<\/p>\n\n\n\n<p>Injuries to or operations on the central nervous system, eyes and ears within the last 2 months.<\/p>\n\n\n\n<p>Disseminated Intravascular Coagulation (DIC) attributable to heparin-induced thrombocytopenia.<\/p>\n\n\n\n<p>Acute bacterial endocarditis and slow endocarditis.<\/p>\n\n\n\n<p>Organic lesions susceptible of bleed (e.g.: active peptic ulcer, haemorrhagic stroke, cerebral aneurysm or cerebral neoplasms).<\/p>\n\n\n\n<p><strong>Special Warnings Precautions<\/strong><\/p>\n\n\n\n<p>Do not administer by the intramuscular route.<\/p>\n\n\n\n<p>Caution should be exercised in cases of liver or renal failure, uncontrolled arterial hypertension, history of gastro-duodenal ulcer disease, thrombocytopenia, nephrolithiasis and\/or urethrolithiasis, choroid and retinal vascular disease, or any other organic lesion susceptible of bleed, or in patients undergoing spinal or epidural anaesthesia and\/or lumbar puncture.<\/p>\n\n\n\n<p><strong>Interaction<\/strong><\/p>\n\n\n\n<p>The concomitant administration of bemiparin and the following medicinal products is not advisable:<\/p>\n\n\n\n<p>Vitamin K antagonists and other anticoagulants, acetyl salicylic acid and other salicylates and NSAIDs, ticlopidine, clopidogrel and other platelet inhibitors systemic glucocorticoids and dextran.<\/p>\n\n\n\n<p><strong>License Name<\/strong><\/p>\n\n\n\n<p>\u0e1a\u0e23\u0e34\u0e29\u0e31\u0e17 \u0e2a\u0e15\u0e32\u0e14\u0e32 (\u0e1b\u0e23\u0e30\u0e40\u0e17\u0e28\u0e44\u0e17\u0e22) \u0e08\u0e33\u0e01\u0e31\u0e14<\/p>\n\n\n\n<p><strong>Distributor Name<\/strong><\/p>\n\n\n\n<p>\u0e1a\u0e23\u0e34\u0e29\u0e31\u0e17 \u0e14\u0e35\u0e40\u0e04\u0e40\u0e2d\u0e2a\u0e40\u0e2d\u0e0a (\u0e1b\u0e23\u0e30\u0e40\u0e17\u0e28\u0e44\u0e17\u0e22) \u0e08\u0e33\u0e01\u0e31\u0e14<\/p>\n\n\n\n<p><strong>Marketing Authorisation Number<\/strong><\/p>\n\n\n\n<p>1C 16\/61 (NB), 1C 17\/61 (NB), 1C 18\/61 (NB), 1C 19\/61 (NB), 1C 20\/61 (NB)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Indication Hibor 2500 I.U. &amp; 3500 I.U.&nbsp;Prevention of venous thromboembolism (VTE) Hibor 5000 I.U., 7500 I.U., 10000 I.U.&nbsp;Treatment of venous thromboembolism (VTE) Qualitative Quantitative Composition Bemiparin sodium 2,500 IU (anti-Xa)\/0.2 ml Bemiparin sodium 3500 IU\/0.2 ml Bemiparin sodium 5,000 IU (anti-Xa)\/0.2 ml Bemiparin sodium 7,500 IU (anti-Xa)\/0.3 ml Bemiparin sodium 10,000 IU (anti-Xa)\/0.4 ml Pharmaceutical Dose Form Solution for injection in pre-filled syringe Dose And Administration General surgery with moderate risk of venous thromboembolism: On the day of the surgical procedure, 2,500 IU anti-Xa is to be administered by subcutaneous route (sc), 2 hours before or 6 hours after surgery. On subsequent days, 2,500 IU anti-Xa sc is to be administered every 24 hours. Prevention of thromboembolic disease in non-surgical patients: The recommended posology of bemiparin is 2.500 IU\/day or 3.500 IU\/day by sc route, according to whether the set of risk factors of the patient defines as mild or high thromboembolic risk. Prevention of clotting in the extracorporeal circulation circuit during haemodialysis For patients undergoing repeated haemodialysis sessions of no longer than 4 hours in duration and with no risk of bleeding, the prevention of clotting in the extracorporeal circulation circuit is obtained by injecting a single dose in the form of bolus into the arterial line at the beginning of the dialysis session. For patients weighing less than 60 kg, the dose to be administered will be 2,500 IU, whereas for patients weighing more than 60 kg, the dose to be administered will be 3,500 IU. Treatment of venous thromboembolism (VTE) HIBOR should be administered by subcutaneous route at the fixed dose of 115 IU anti-Xa\/kg weight\/day, during 7 \u00b1 2 days as a general rule. This daily dose generally correspondes, depending on the body weight, to the ranges: &lt;50 kg, 0.2 ml (5,000 IU anti-Xa); 50-70 kg, 0.3 ml (7,500 IU anti-Xa) ; 70-100 kg, 0.4 ml (10,000 IU anti-Xa) and 100-120 kg, 0.5 ml (12,500 IU anti-Xa). In patients of &gt; 120 kg of weight, the dose to be administered must be adjusted to the weight, at a rate of 115 IU anti-Xa\/kg\/day. Contraindications Hypersensitivity to bemiparin sodium, heparin or substances of porcine origin. History of confirmed or suspected immunologically mediated heparin induced thrombocytopenia (HIT). Active haemorrhage or increased risk of bleeding due to impairment of haemostasis. Severe impairment of liver or pancreatic function. Injuries to or operations on the central nervous system, eyes and ears within the last 2 months. Disseminated Intravascular Coagulation (DIC) attributable to heparin-induced thrombocytopenia. Acute bacterial endocarditis and slow endocarditis. Organic lesions susceptible of bleed (e.g.: active peptic ulcer, haemorrhagic stroke, cerebral aneurysm or cerebral neoplasms). Special Warnings Precautions Do not administer by the intramuscular route. Caution should be exercised in cases of liver or renal failure, uncontrolled arterial hypertension, history of gastro-duodenal ulcer disease, thrombocytopenia, nephrolithiasis and\/or urethrolithiasis, choroid and retinal vascular disease, or any other organic lesion susceptible of bleed, or in patients undergoing spinal or epidural anaesthesia and\/or lumbar puncture. Interaction The concomitant administration of bemiparin and the following medicinal products is not advisable: Vitamin K antagonists and other anticoagulants, acetyl salicylic acid and other salicylates and NSAIDs, ticlopidine, clopidogrel and other platelet inhibitors systemic glucocorticoids and dextran. License Name \u0e1a\u0e23\u0e34\u0e29\u0e31\u0e17 \u0e2a\u0e15\u0e32\u0e14\u0e32 (\u0e1b\u0e23\u0e30\u0e40\u0e17\u0e28\u0e44\u0e17\u0e22) \u0e08\u0e33\u0e01\u0e31\u0e14 Distributor Name \u0e1a\u0e23\u0e34\u0e29\u0e31\u0e17 \u0e14\u0e35\u0e40\u0e04\u0e40\u0e2d\u0e2a\u0e40\u0e2d\u0e0a (\u0e1b\u0e23\u0e30\u0e40\u0e17\u0e28\u0e44\u0e17\u0e22) \u0e08\u0e33\u0e01\u0e31\u0e14 Marketing Authorisation Number 1C 16\/61 (NB), 1C 17\/61 (NB), 1C 18\/61 (NB), 1C 19\/61 (NB), 1C 20\/61 (NB)<\/p>\n","protected":false},"author":239871753,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"advanced_seo_description":"","jetpack_seo_html_title":"","jetpack_seo_noindex":false,"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[765567860],"tags":[],"class_list":["post-288","post","type-post","status-publish","format-standard","hentry","category-stada-thailand-co-ltd"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/sfzQll-hibor","jetpack-related-posts":[{"id":238,"url":"https:\/\/score.ccme.or.th\/ccme-wp\/2023\/09\/25\/apixaban-tablets\/","url_meta":{"origin":288,"position":0},"title":"Apixaban Tablets","author":"CCME","date":"September 25, 2023","format":false,"excerpt":"Indication \u0e43\u0e0a\u0e49\u0e1b\u0e49\u0e2d\u0e07\u0e01\u0e31\u0e19\u0e20\u0e32\u0e27\u0e30\u0e01\u0e32\u0e23\u0e40\u0e01\u0e34\u0e14\u0e25\u0e34\u0e48\u0e21\u0e40\u0e25\u0e37\u0e2d\u0e14\u0e2d\u0e38\u0e14\u0e15\u0e31\u0e19\u0e43\u0e19\u0e2b\u0e25\u0e2d\u0e14\u0e40\u0e25\u0e37\u0e2d\u0e14\u0e14\u0e33 (venous thromboembolic events) \u0e43\u0e19\u0e1c\u0e39\u0e49\u0e1b\u0e48\u0e27\u0e22\u0e1c\u0e39\u0e49\u0e43\u0e2b\u0e0d\u0e48\u0e17\u0e35\u0e48\u0e44\u0e14\u0e49\u0e23\u0e31\u0e1a\u0e01\u0e32\u0e23\u0e1c\u0e48\u0e32\u0e15\u0e31\u0e14\u0e40\u0e1b\u0e25\u0e35\u0e48\u0e22\u0e19\u0e02\u0e49\u0e2d\u0e2a\u0e30\u0e42\u0e1e\u0e01\u0e40\u0e17\u0e35\u0e22\u0e21\u0e2b\u0e23\u0e37\u0e2d\u0e02\u0e49\u0e2d\u0e40\u0e02\u0e48\u0e32\u0e40\u0e17\u0e35\u0e22\u0e21 \u0e43\u0e0a\u0e49\u0e1b\u0e49\u0e2d\u0e07\u0e01\u0e31\u0e19\u0e01\u0e32\u0e23\u0e40\u0e01\u0e34\u0e14\u0e20\u0e32\u0e27\u0e30\u0e25\u0e34\u0e48\u0e21\u0e40\u0e25\u0e37\u0e2d\u0e14\u0e2d\u0e38\u0e14\u0e15\u0e31\u0e19\u0e2b\u0e25\u0e2d\u0e14\u0e40\u0e25\u0e37\u0e2d\u0e14\u0e43\u0e19\u0e2a\u0e21\u0e2d\u0e07\u0e41\u0e25\u0e30\u0e2b\u0e25\u0e2d\u0e14\u0e40\u0e25\u0e37\u0e2d\u0e14\u0e2d\u0e37\u0e48\u0e19\u0e17\u0e31\u0e48\u0e27\u0e23\u0e48\u0e32\u0e07\u0e01\u0e32\u0e22 \u0e08\u0e32\u0e01\u0e20\u0e32\u0e27\u0e30 atrial fibrillation \u0e17\u0e35\u0e48\u0e44\u0e21\u0e48\u0e40\u0e01\u0e35\u0e48\u0e22\u0e27\u0e02\u0e49\u0e2d\u0e07\u0e01\u0e31\u0e1a\u0e25\u0e34\u0e49\u0e19\u0e2b\u0e31\u0e27\u0e43\u0e08 (non-valvular atrial fibrillation) \u0e0b\u0e36\u0e48\u0e07\u0e21\u0e35\u0e1b\u0e31\u0e08\u0e08\u0e31\u0e22\u0e40\u0e2a\u0e35\u0e48\u0e22\u0e07\u0e2d\u0e22\u0e48\u0e32\u0e07\u0e19\u0e49\u0e2d\u0e22 1 \u0e2d\u0e22\u0e48\u0e32\u0e07 \u0e23\u0e27\u0e21\u0e16\u0e36\u0e07\u0e1c\u0e39\u0e49\u0e1b\u0e48\u0e27\u0e22\u0e17\u0e35\u0e48\u0e44\u0e21\u0e48\u0e40\u0e2b\u0e21\u0e32\u0e30\u0e2a\u0e21\u0e01\u0e31\u0e1a\u0e01\u0e32\u0e23\u0e23\u0e31\u0e01\u0e29\u0e32\u0e14\u0e49\u0e27\u0e22 warfarin \u0e40\u0e21\u0e37\u0e48\u0e2d\u0e40\u0e1b\u0e23\u0e35\u0e22\u0e1a\u0e40\u0e17\u0e35\u0e22\u0e1a\u0e01\u0e31\u0e1a warfarin \u0e23\u0e31\u0e01\u0e29\u0e32\u0e20\u0e32\u0e27\u0e30\u0e25\u0e34\u0e48\u0e21\u0e40\u0e25\u0e37\u0e2d\u0e14\u0e2d\u0e38\u0e14\u0e15\u0e31\u0e19\u0e43\u0e19\u0e2b\u0e25\u0e2d\u0e14\u0e40\u0e25\u0e37\u0e2d\u0e14\u0e14\u0e33\u0e2a\u0e48\u0e27\u0e19\u0e25\u0e36\u0e01 (DVT) \u0e41\u0e25\u0e30\u0e20\u0e32\u0e27\u0e30\u0e01\u0e32\u0e23\u0e40\u0e01\u0e34\u0e14\u0e25\u0e34\u0e48\u0e21\u0e40\u0e25\u0e37\u0e2d\u0e14\u0e2d\u0e38\u0e14\u0e15\u0e31\u0e19\u0e43\u0e19\u0e2b\u0e25\u0e2d\u0e14\u0e40\u0e25\u0e37\u0e2d\u0e14\u0e41\u0e14\u0e07\u0e1b\u0e2d\u0e14 (PE) \u0e1b\u0e49\u0e2d\u0e07\u0e01\u0e31\u0e19\u0e01\u0e32\u0e23\u0e40\u0e01\u0e34\u0e14\u0e0b\u0e4d\u0e49\u0e32\u0e02\u0e2d\u0e07\u0e20\u0e32\u0e27\u0e30\u0e25\u0e34\u0e48\u0e21\u0e40\u0e25\u0e37\u0e2d\u0e14\u0e2d\u0e38\u0e14\u0e15\u0e31\u0e19\u0e43\u0e19\u0e2b\u0e25\u0e2d\u0e14\u0e40\u0e25\u0e37\u0e2d\u0e14\u0e14\u0e33\u0e2a\u0e48\u0e27\u0e19\u0e25\u0e36\u0e01 (DVT) \u0e41\u0e25\u0e30\u0e20\u0e32\u0e27\u0e30\u0e01\u0e32\u0e23\u0e40\u0e01\u0e34\u0e14\u0e25\u0e34\u0e48\u0e21\u0e40\u0e25\u0e37\u0e2d\u0e14\u0e2d\u0e38\u0e14\u0e15\u0e31\u0e19\u0e43\u0e19\u0e2b\u0e25\u0e2d\u0e14\u0e40\u0e25\u0e37\u0e2d\u0e14\u0e41\u0e14\u0e07\u0e1b\u0e2d\u0e14 (PE) Qualitative Quantitative Composition Apixaban 2.5 \u0e41\u0e25\u0e30 5 mg Pharmaceutical Dose Form Film coated tablet Dose And Administration \u0e2a\u0e33\u0e2b\u0e23\u0e31\u0e1a\u0e1b\u0e49\u0e2d\u0e07\u0e01\u0e31\u0e19\u0e20\u0e32\u0e27\u0e30\u0e01\u0e32\u0e23\u0e40\u0e01\u0e34\u0e14\u0e25\u0e34\u0e48\u0e21\u0e40\u0e25\u0e37\u0e2d\u0e14\u0e2d\u0e38\u0e14\u0e15\u0e31\u0e19\u0e43\u0e19\u0e2b\u0e25\u0e2d\u0e14\u0e40\u0e25\u0e37\u0e2d\u0e14\u0e14\u0e33 VTE: \u0e08\u0e32\u0e01\u0e01\u0e32\u0e23\u0e1c\u0e48\u0e32\u0e15\u0e31\u0e14\u0e40\u0e1b\u0e25\u0e35\u0e48\u0e22\u0e19\u0e02\u0e49\u0e2d\u0e2a\u0e30\u0e42\u0e1e\u0e01\u0e40\u0e17\u0e35\u0e22\u0e21\u0e2b\u0e23\u0e37\u0e2d\u0e02\u0e49\u0e2d\u0e40\u0e02\u0e48\u0e32\u0e40\u0e17\u0e35\u0e22\u0e21\u00a0\u0e02\u0e19\u0e32\u0e14\u0e17\u0e35\u0e48\u0e41\u0e19\u0e30\u0e19\u0e33\u0e02\u0e2d\u0e07 apixaban\u2026","rel":"","context":"In &quot;Atlanta Medicare Co., Ltd.&quot;","block_context":{"text":"Atlanta Medicare Co., Ltd.","link":"https:\/\/score.ccme.or.th\/ccme-wp\/category\/atlanta-medicare-co-ltd\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/09\/apixaban-004.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/09\/apixaban-004.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/09\/apixaban-004.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/09\/apixaban-004.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/09\/apixaban-004.png?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":233,"url":"https:\/\/score.ccme.or.th\/ccme-wp\/2023\/09\/25\/utoin-250\/","url_meta":{"origin":288,"position":1},"title":"Utoin-250","author":"CCME","date":"September 25, 2023","format":false,"excerpt":"Indication \u0e23\u0e31\u0e01\u0e29\u0e32\u0e42\u0e23\u0e04\u0e25\u0e21\u0e0a\u0e31\u0e01\u0e0a\u0e19\u0e34\u0e14 tonic-clonic (grand mal) \u0e41\u0e25\u0e30 simple \u0e2b\u0e23\u0e37\u0e2d complex partial (psychomotor \u0e2b\u0e23\u0e37\u0e2d temporal lobe) \u0e43\u0e0a\u0e49\u0e41\u0e01\u0e49\u0e2d\u0e32\u0e01\u0e32\u0e23\u0e2b\u0e31\u0e27\u0e43\u0e08\u0e40\u0e15\u0e49\u0e19\u0e40\u0e2a\u0e35\u0e22\u0e08\u0e31\u0e07\u0e2b\u0e27\u0e30\u0e08\u0e32\u0e01\u0e1e\u0e34\u0e29\u0e02\u0e2d\u0e07\u0e22\u0e32 Digitalis (ventricular arrhythmia) \u0e23\u0e31\u0e01\u0e29\u0e32\u0e41\u0e25\u0e30\u0e1b\u0e49\u0e2d\u0e07\u0e01\u0e31\u0e19\u0e01\u0e32\u0e23\u0e0a\u0e31\u0e01\u0e08\u0e32\u0e01\u0e01\u0e32\u0e23\u0e1c\u0e48\u0e32\u0e15\u0e31\u0e14\u0e2a\u0e21\u0e2d\u0e07 \u0e43\u0e0a\u0e49\u0e04\u0e27\u0e1a\u0e04\u0e38\u0e21\u0e2d\u0e32\u0e01\u0e32\u0e23\u0e0a\u0e31\u0e01\u0e41\u0e1a\u0e1a status epilepticus Qualitative Quantitative Composition API: Phenytoin Sodium 250 mg\/5 mL Excipient: Ethanol Pharmaceutical Dose Form Solution for Injection Dose And Administration \u0e02\u0e19\u0e32\u0e14\u0e22\u0e32\u0e40\u0e23\u0e34\u0e48\u0e21\u0e15\u0e49\u0e19 15-20 \u0e21\u0e01.\/\u0e01\u0e01. \u0e08\u0e32\u0e01\u0e19\u0e31\u0e49\u0e19\u0e15\u0e32\u0e21\u0e14\u0e49\u0e27\u0e22 100 \u0e21\u0e01. \u0e17\u0e38\u0e01 6\u2026","rel":"","context":"In &quot;Able Medical Co., Ltd&quot;","block_context":{"text":"Able Medical Co., Ltd","link":"https:\/\/score.ccme.or.th\/ccme-wp\/category\/able-medical-co-ltd\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/09\/utoin-250-napatphan-boongasem.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/09\/utoin-250-napatphan-boongasem.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/09\/utoin-250-napatphan-boongasem.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/09\/utoin-250-napatphan-boongasem.png?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":394,"url":"https:\/\/score.ccme.or.th\/ccme-wp\/2023\/11\/10\/ducressa\/","url_meta":{"origin":288,"position":2},"title":"Ducressa","author":"CCME","date":"November 10, 2023","format":false,"excerpt":"Indication \u0e22\u0e32\u0e2b\u0e22\u0e2d\u0e14\u0e15\u0e32 Ducressa \u0e21\u0e35\u0e02\u0e49\u0e2d\u0e1a\u0e48\u0e07\u0e43\u0e0a\u0e49\u0e43\u0e19\u0e01\u0e32\u0e23\u0e1b\u0e49\u0e2d\u0e07\u0e01\u0e31\u0e19\u0e41\u0e25\u0e30\u0e23\u0e31\u0e01\u0e29\u0e32\u0e01\u0e32\u0e23\u0e2d\u0e31\u0e01\u0e40\u0e2a\u0e1a\u0e02\u0e2d\u0e07\u0e14\u0e27\u0e07\u0e15\u0e32 \u0e41\u0e25\u0e30\u0e43\u0e0a\u0e49\u0e1b\u0e49\u0e2d\u0e07\u0e01\u0e31\u0e19\u0e01\u0e32\u0e23\u0e15\u0e34\u0e14\u0e40\u0e0a\u0e37\u0e49\u0e2d\u0e17\u0e35\u0e48\u0e2a\u0e31\u0e21\u0e1e\u0e31\u0e19\u0e18\u0e4c\u0e01\u0e31\u0e1a\u0e01\u0e32\u0e23\u0e1c\u0e48\u0e32\u0e15\u0e31\u0e14\u0e15\u0e49\u0e2d\u0e01\u0e23\u0e30\u0e08\u0e01\u0e43\u0e19\u0e1c\u0e39\u0e49\u0e43\u0e2b\u0e0d\u0e48 Qualitative Quantitative Composition \u0e44\u0e14\u0e04\u0e27\u0e2d\u0e42\u0e1f\u0e0b\u0e2d\u0e25 \u0e42\u0e0b\u0e40\u0e14\u0e35\u0e22\u0e21 30 \u0e21\u0e34\u0e25\u0e25\u0e34\u0e01\u0e23\u0e31\u0e21 Pharmaceutical Dose Form \u0e2a\u0e32\u0e23\u0e25\u0e30\u0e25\u0e32\u0e22\u0e43\u0e2a\u0e2a\u0e33\u0e2b\u0e23\u0e31\u0e1a\u0e2b\u0e22\u0e2d\u0e14\u0e15\u0e32 \u0e1b\u0e23\u0e32\u0e28\u0e08\u0e32\u0e01\u0e40\u0e0a\u0e37\u0e49\u0e2d \u0e2a\u0e35\u0e40\u0e2b\u0e25\u0e37\u0e2d\u0e07\u0e08\u0e32\u0e07\u0e16\u0e36\u0e07\u0e40\u0e2b\u0e25\u0e37\u0e2d\u0e07 Dose And Administration \u0e2b\u0e22\u0e2d\u0e14\u0e22\u0e32 1 \u0e2b\u0e22\u0e14 \u0e43\u0e19\u0e16\u0e38\u0e07\u0e40\u0e22\u0e37\u0e48\u0e2d\u0e1a\u0e38\u0e15\u0e32\u0e2b\u0e25\u0e31\u0e07\u0e08\u0e32\u0e01\u0e1c\u0e48\u0e32\u0e15\u0e31\u0e14 \u0e17\u0e38\u0e01 6\u0e0a\u0e31\u0e48\u0e27\u0e42\u0e21\u0e07 \u0e42\u0e14\u0e22\u0e21\u0e35\u0e23\u0e30\u0e22\u0e30\u0e40\u0e27\u0e25\u0e32\u0e43\u0e19\u0e01\u0e32\u0e23\u0e23\u0e31\u0e01\u0e29\u0e32\u0e04\u0e37\u0e2d 7\u0e27\u0e31\u0e19 \u0e41\u0e25\u0e30\u0e44\u0e21\u0e48\u0e04\u0e27\u0e23\u0e2b\u0e22\u0e38\u0e14\u0e01\u0e32\u0e23\u0e23\u0e31\u0e01\u0e29\u0e32\u0e01\u0e48\u0e2d\u0e19\u0e23\u0e30\u0e22\u0e30\u0e40\u0e27\u0e25\u0e32\u0e17\u0e35\u0e48\u0e01\u0e4d\u0e32\u0e2b\u0e19\u0e14\u0e44\u0e27\u0e49 \u0e2b\u0e32\u0e01\u0e25\u0e37\u0e21\u0e2b\u0e22\u0e2d\u0e14\u0e22\u0e32 1 \u0e04\u0e23\u0e31\u0e49\u0e07 \u0e04\u0e27\u0e23\u0e2b\u0e22\u0e2d\u0e14\u0e22\u0e32\u0e43\u0e19\u0e04\u0e23\u0e31\u0e49\u0e07\u0e16\u0e31\u0e14\u0e44\u0e1b\u0e15\u0e32\u0e21\u0e01\u0e4d\u0e32\u0e2b\u0e19\u0e14 \u0e41\u0e19\u0e30\u0e19\u0e4d\u0e32\u0e43\u0e2b\u0e49\u0e17\u0e4d\u0e32\u0e01\u0e32\u0e23\u0e1b\u0e23\u0e30\u0e40\u0e21\u0e34\u0e19\u0e1c\u0e39\u0e49\u0e1b\u0e48\u0e27\u0e22\u0e2d\u0e35\u0e01\u0e04\u0e23\u0e31\u0e49\u0e07 \u0e40\u0e1e\u0e37\u0e48\u0e2d\u0e14\u0e39\u0e04\u0e27\u0e32\u0e21\u0e08\u0e4d\u0e32\u0e40\u0e1b\u0e47\u0e19\u0e43\u0e19\u0e01\u0e32\u0e23\u0e23\u0e31\u0e01\u0e29\u0e32\u0e14\u0e49\u0e27\u0e22\u0e22\u0e32\u0e2b\u0e22\u0e2d\u0e14\u0e15\u0e32\u0e01\u0e25\u0e38\u0e48\u0e21\u0e04\u0e2d\u0e23\u0e4c\u0e15\u0e34\u0e42\u0e04\u0e2a\u0e40\u0e15\u0e35\u0e22\u0e23\u0e2d\u0e22\u0e14\u0e4c\u0e2d\u0e22\u0e48\u0e32\u0e07\u0e40\u0e14\u0e35\u0e22\u0e27\u0e15\u0e48\u0e2d\u0e2b\u0e25\u0e31\u0e07\u0e08\u0e32\u0e01\u0e40\u0e2a\u0e23\u0e47\u0e08\u0e2a\u0e34\u0e49\u0e19\u0e01\u0e32\u0e23\u0e23\u0e31\u0e01\u0e29\u0e32\u0e14\u0e49\u0e27\u0e22\u0e22\u0e32 Ducressa \u0e40\u0e1b\u0e47\u0e19\u0e40\u0e27\u0e25\u0e32 1 \u0e2a\u0e31\u0e1b\u0e14\u0e32\u0e2b\u0e4c \u0e23\u0e30\u0e22\u0e30\u0e40\u0e27\u0e25\u0e32\u0e43\u0e19\u0e01\u0e32\u0e23\u0e23\u0e31\u0e01\u0e29\u0e32\u0e02\u0e36\u0e49\u0e19\u0e2d\u0e22\u0e39\u0e48\u0e01\u0e31\u0e1a\u0e1b\u0e31\u0e08\u0e08\u0e31\u0e22\u0e40\u0e2a\u0e35\u0e48\u0e22\u0e07\u0e02\u0e2d\u0e07\u0e1c\u0e39\u0e49\u0e1b\u0e48\u0e27\u0e22\u0e41\u0e25\u0e30\u0e1c\u0e25\u0e01\u0e32\u0e23\u0e1c\u0e48\u0e32\u0e15\u0e31\u0e14 \u0e41\u0e25\u0e30\u0e15\u0e49\u0e2d\u0e07\u0e01\u0e4d\u0e32\u0e2b\u0e19\u0e14\u0e42\u0e14\u0e22\u0e41\u0e1e\u0e17\u0e22\u0e4c\u0e08\u0e32\u0e01\u0e01\u0e32\u0e23\u0e15\u0e23\u0e27\u0e08\u0e14\u0e49\u0e27\u0e22\u0e01\u0e25\u0e49\u0e2d\u0e07\u0e15\u0e23\u0e27\u0e08\u0e15\u0e32 slit-lamp microscopic \u0e41\u0e25\u0e30\u0e22\u0e31\u0e07\u0e02\u0e36\u0e49\u0e19\u0e2d\u0e22\u0e39\u0e48\u0e01\u0e31\u0e1a\u0e04\u0e27\u0e32\u0e21\u0e23\u0e38\u0e19\u0e41\u0e23\u0e07\u0e17\u0e32\u0e07\u0e04\u0e25\u0e34\u0e19\u0e34\u0e01\u0e14\u0e49\u0e27\u0e22 \u0e01\u0e32\u0e23\u0e23\u0e31\u0e01\u0e29\u0e32 \u0e15\u0e34\u0e14\u0e15\u0e32\u0e21\u0e1c\u0e25\u0e14\u0e49\u0e27\u0e22\u0e22\u0e32\u0e2b\u0e22\u0e2d\u0e14\u0e15\u0e32\u0e2a\u0e40\u0e15\u0e35\u0e22\u0e23\u0e2d\u0e22\u0e14\u0e4c \u0e1b\u0e01\u0e15\u0e34\u0e41\u0e25\u0e49\u0e27\u0e44\u0e21\u0e48\u0e04\u0e27\u0e23\u0e23\u0e31\u0e01\u0e29\u0e32\u0e40\u0e01\u0e34\u0e19 2 \u0e2a\u0e31\u0e1b\u0e14\u0e32\u0e2b\u0e4c\u2026","rel":"","context":"In &quot;Company Highlight&quot;","block_context":{"text":"Company Highlight","link":"https:\/\/score.ccme.or.th\/ccme-wp\/category\/company-highlight\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/11\/ducressa-box-bottle-02-upsorn-pitaktong-edited.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/11\/ducressa-box-bottle-02-upsorn-pitaktong-edited.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/11\/ducressa-box-bottle-02-upsorn-pitaktong-edited.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/11\/ducressa-box-bottle-02-upsorn-pitaktong-edited.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/11\/ducressa-box-bottle-02-upsorn-pitaktong-edited.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/11\/ducressa-box-bottle-02-upsorn-pitaktong-edited.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":400,"url":"https:\/\/score.ccme.or.th\/ccme-wp\/2023\/11\/10\/hialid%e2%93%a1-mini-0-3\/","url_meta":{"origin":288,"position":3},"title":"Hialid\u24c7 Mini 0.3","author":"CCME","date":"November 10, 2023","format":false,"excerpt":"Indication \u0e0a\u0e48\u0e27\u0e22\u0e43\u0e19\u0e01\u0e32\u0e23\u0e2a\u0e21\u0e32\u0e19\u0e1a\u0e32\u0e14\u0e41\u0e1c\u0e25\u0e41\u0e25\u0e30\u0e04\u0e27\u0e32\u0e21\u0e1c\u0e34\u0e14\u0e1b\u0e01\u0e15\u0e34\u0e02\u0e2d\u0e07\u0e40\u0e22\u0e37\u0e48\u0e2d\u0e1a\u0e38\u0e01\u0e23\u0e30\u0e08\u0e01\u0e15\u0e32\u0e41\u0e25\u0e30\u0e40\u0e22\u0e37\u0e48\u0e2d\u0e15\u0e32\u0e02\u0e32\u0e27\u0e0b\u0e36\u0e48\u0e07\u0e21\u0e35\u0e2a\u0e32\u0e40\u0e2b\u0e15\u0e38\u0e21\u0e32\u0e08\u0e32\u0e01\u2022 \u0e04\u0e27\u0e32\u0e21\u0e1c\u0e34\u0e14\u0e1b\u0e01\u0e15\u0e34\u0e20\u0e32\u0e22\u0e43\u0e19\u0e23\u0e48\u0e32\u0e07\u0e01\u0e32\u0e22 \u0e40\u0e0a\u0e48\u0e19 Sjogren\u2019s syndrome, Stevens-Johnson syndrome\u0e41\u0e25\u0e30 Sicca syndrome (\u0e15\u0e32\u0e41\u0e2b\u0e49\u0e07)\u2022 \u0e04\u0e27\u0e32\u0e21\u0e1c\u0e34\u0e14\u0e1b\u0e01\u0e15\u0e34\u0e17\u0e35\u0e48\u0e21\u0e35\u0e2a\u0e32\u0e40\u0e2b\u0e15\u0e38\u0e08\u0e32\u0e01\u0e01\u0e32\u0e23\u0e1c\u0e48\u0e32\u0e15\u0e31\u0e14 \u0e1c\u0e25\u0e08\u0e32\u0e01\u0e01\u0e32\u0e23\u0e43\u0e0a\u0e49\u0e22\u0e32\u0e2d\u0e38\u0e1a\u0e31\u0e15\u0e34\u0e40\u0e2b\u0e15\u0e38\u0e01\u0e32\u0e23\u0e2a\u0e27\u0e21\u0e43\u0e2a\u0e48\u0e40\u0e25\u0e19\u0e2a\u0e4c\u0e2a\u0e31\u0e21\u0e1c\u0e31\u0e2a (Contact lens) Qualitative Quantitative Composition \u0e43\u0e19 1 \u0e21\u0e34\u0e25\u0e25\u0e34\u0e25\u0e34\u0e15\u0e23 \u0e1b\u0e23\u0e30\u0e01\u0e2d\u0e1a\u0e14\u0e49\u0e27\u0e22\u0e15\u0e31\u0e27\u0e22\u0e32\u0e2a \u0e32\u0e04\u0e31\u0e0d\u0e04\u0e37\u0e2d purified sodium hyaluronate 3 \u0e21\u0e34\u0e25\u0e25\u0e34\u0e01\u0e23\u0e31\u0e21 \u0e2a\u0e48\u0e27\u0e19\u0e1b\u0e23\u0e30\u0e01\u0e2d\u0e1a\u0e2d\u0e37\u0e48\u0e19 \u0e46 \u0e44\u0e14\u0e49\u0e41\u0e01\u0e48 \u025b-aminocaproic acid \u0e41\u0e25\u0e30 disodium edetate hydrate Pharmaceutical Dose Form \u0e22\u0e32\u0e2b\u0e22\u0e2d\u0e14\u0e15\u0e32 Hialid\u24c7 Mini 0.3\u0e40\u0e1b\u0e47\u0e19\u0e19\u0e49\u0e33\u0e22\u0e32\u0e1b\u0e23\u0e32\u0e28\u0e08\u0e32\u0e01\u0e40\u0e0a\u0e37\u0e49\u0e2d \u0e2b\u0e19\u0e37\u0e14 \u0e43\u0e2a \u0e44\u0e21\u0e48\u0e21\u0e35\u0e2a\u0e35 Dose And Administration\u2026","rel":"","context":"In &quot;Company Highlight&quot;","block_context":{"text":"Company Highlight","link":"https:\/\/score.ccme.or.th\/ccme-wp\/category\/company-highlight\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/11\/hialid-mini-0.3-20-upsorn-pitaktong.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/11\/hialid-mini-0.3-20-upsorn-pitaktong.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/11\/hialid-mini-0.3-20-upsorn-pitaktong.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/11\/hialid-mini-0.3-20-upsorn-pitaktong.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/11\/hialid-mini-0.3-20-upsorn-pitaktong.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2023\/11\/hialid-mini-0.3-20-upsorn-pitaktong.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":1116,"url":"https:\/\/score.ccme.or.th\/ccme-wp\/2024\/01\/31\/nicardipine-2-mg-2-ml-%e0%b9%81%e0%b8%a5%e0%b8%b0-10-mg-10-ml\/","url_meta":{"origin":288,"position":4},"title":"Cardepine Injection","author":"CCME","date":"January 31, 2024","format":false,"excerpt":"Indication 1. \u0e23\u0e31\u0e01\u0e29\u0e32\u0e04\u0e27\u0e32\u0e21\u0e14\u0e31\u0e19\u0e42\u0e25\u0e2b\u0e34\u0e15\u0e2a\u0e39\u0e07\u0e02\u0e31\u0e49\u0e19\u0e1b\u0e32\u0e19\u0e01\u0e25\u0e32\u0e07-\u0e23\u0e38\u0e19\u0e41\u0e23\u0e07 \u0e0b\u0e36\u0e48\u0e07\u0e08\u0e33\u0e40\u0e1b\u0e47\u0e19\u0e15\u0e49\u0e2d\u0e07\u0e25\u0e14\u0e04\u0e27\u0e32\u0e21\u0e14\u0e31\u0e19\u0e42\u0e25\u0e2b\u0e34\u0e15\u0e25\u0e07\u0e17\u0e31\u0e19\u0e17\u0e35 \u0e40\u0e0a\u0e48\u0e19 hypertensive emergency \u0e2b\u0e23\u0e37\u0e2d urgencies2. \u0e04\u0e27\u0e32\u0e21\u0e14\u0e31\u0e19\u0e42\u0e25\u0e2b\u0e34\u0e15\u0e2a\u0e39\u0e07\u0e23\u0e30\u0e2b\u0e27\u0e48\u0e32\u0e07\u0e41\u0e25\u0e30\u0e2b\u0e25\u0e31\u0e07\u0e1c\u0e48\u0e32\u0e15\u0e31\u0e143. \u0e23\u0e31\u0e01\u0e29\u0e32\u0e04\u0e27\u0e32\u0e21\u0e14\u0e31\u0e19\u0e42\u0e25\u0e2b\u0e34\u0e15\u0e2a\u0e39\u0e07\u0e43\u0e19\u0e23\u0e30\u0e22\u0e30\u0e2a\u0e31\u0e49\u0e19\u0e40\u0e21\u0e37\u0e48\u0e2d\u0e44\u0e21\u0e48\u0e2a\u0e32\u0e21\u0e32\u0e23\u0e16\u0e43\u0e0a\u0e49\u0e22\u0e32\u0e43\u0e19\u0e23\u0e39\u0e1b\u0e23\u0e31\u0e1a\u0e1b\u0e23\u0e30\u0e17\u0e32\u0e19\u0e44\u0e14\u0e49 Qualitative Quantitative Composition Nicardipine 2 mg\/2 ml \u0e41\u0e25\u0e30 10 mg\/10 ml Pharmaceutical Dose Form Solution for Injection Dose And Administration \u0e40\u0e08\u0e37\u0e2d\u0e08\u0e32\u0e07\u0e22\u0e32\u0e43\u0e2b\u0e49\u0e44\u0e14\u0e49\u0e04\u0e27\u0e32\u0e21\u0e40\u0e02\u0e49\u0e21\u0e02\u0e49\u0e19 0.1 mg\/ml \u0e43\u0e2b\u0e49\u0e22\u0e32\u0e42\u0e14\u0e22\u0e2b\u0e22\u0e14\u0e40\u0e02\u0e49\u0e32\u0e2b\u0e25\u0e2d\u0e14\u0e40\u0e25\u0e37\u0e2d\u0e14\u0e14\u0e33\u0e0a\u0e49\u0e32\u0e46 \u0e2d\u0e22\u0e48\u0e32\u0e07\u0e15\u0e48\u0e2d\u0e40\u0e19\u0e37\u0e48\u0e2d\u0e07\u0e43\u0e19\u0e2d\u0e31\u0e15\u0e23\u0e32\u0e40\u0e23\u0e34\u0e48\u0e21\u0e15\u0e49\u0e19 50 mg\/hr \u0e1b\u0e23\u0e31\u0e1a\u0e40\u0e1e\u0e34\u0e48\u0e21\u0e02\u0e19\u0e32\u0e14\u0e22\u0e32\u0e04\u0e23\u0e31\u0e49\u0e07\u0e25\u0e30 2.5 mg\/hr \u0e17\u0e38\u0e01 15 \u0e19\u0e32\u0e17\u0e35 \u0e42\u0e14\u0e22\u0e2d\u0e31\u0e15\u0e23\u0e32\u0e01\u0e32\u0e23\u0e43\u0e2b\u0e49\u0e22\u0e32\u0e2a\u0e39\u0e07\u0e2a\u0e38\u0e14\u0e44\u0e21\u0e48\u0e04\u0e27\u0e23\u0e40\u0e01\u0e34\u0e19 15 mg\/hr Contraindications 1. \u0e1c\u0e39\u0e49\u0e1b\u0e48\u0e27\u0e22\u0e17\u0e35\u0e48\u0e17\u0e23\u0e32\u0e1a\u0e27\u0e48\u0e32\u0e40\u0e01\u0e34\u0e14\u0e1b\u0e0f\u0e34\u0e01\u0e34\u0e23\u0e34\u0e22\u0e32\u0e20\u0e39\u0e21\u0e34\u0e44\u0e27\u0e40\u0e01\u0e34\u0e19\u0e15\u0e48\u0e2d\u0e22\u0e32\u2026","rel":"","context":"In &quot;Great Eastern Drug Co., Ltd.&quot;","block_context":{"text":"Great Eastern Drug Co., Ltd.","link":"https:\/\/score.ccme.or.th\/ccme-wp\/category\/great-eastern-drug-co-ltd\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2024\/01\/Cardepin-10mg-and-2-mg-Samart-Suntornsuk.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2024\/01\/Cardepin-10mg-and-2-mg-Samart-Suntornsuk.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2024\/01\/Cardepin-10mg-and-2-mg-Samart-Suntornsuk.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2024\/01\/Cardepin-10mg-and-2-mg-Samart-Suntornsuk.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2024\/01\/Cardepin-10mg-and-2-mg-Samart-Suntornsuk.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2024\/01\/Cardepin-10mg-and-2-mg-Samart-Suntornsuk.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":1119,"url":"https:\/\/score.ccme.or.th\/ccme-wp\/2024\/01\/31\/renogen-4000-units-ml-injection\/","url_meta":{"origin":288,"position":5},"title":"Renogen 4000 Units\/ml Injection","author":"CCME","date":"January 31, 2024","format":false,"excerpt":"Indication - \u0e01\u0e32\u0e23\u0e23\u0e31\u0e01\u0e29\u0e32\u0e42\u0e25\u0e2b\u0e34\u0e15\u0e08\u0e32\u0e07\u0e43\u0e19\u0e1c\u0e39\u0e49\u0e1b\u0e48\u0e27\u0e22\u0e44\u0e15\u0e27\u0e32\u0e22\u0e40\u0e23\u0e37\u0e49\u0e2d\u0e23\u0e31\u0e07- \u0e01\u0e32\u0e23\u0e23\u0e31\u0e01\u0e29\u0e32\u0e42\u0e25\u0e2b\u0e34\u0e15\u0e08\u0e32\u0e07\u0e43\u0e19\u0e1c\u0e39\u0e49\u0e1b\u0e48\u0e27\u0e22 HIV \u0e17\u0e35\u0e48\u0e44\u0e14\u0e49\u0e23\u0e31\u0e1a\u0e22\u0e32 zidovudine- \u0e01\u0e32\u0e23\u0e23\u0e31\u0e01\u0e29\u0e32\u0e42\u0e25\u0e2b\u0e34\u0e15\u0e08\u0e32\u0e07\u0e43\u0e19\u0e1c\u0e39\u0e49\u0e1b\u0e48\u0e27\u0e22\u0e21\u0e30\u0e40\u0e23\u0e47\u0e07\u0e17\u0e35\u0e48\u0e44\u0e14\u0e49\u0e23\u0e31\u0e1a\u0e22\u0e32\u0e40\u0e04\u0e21\u0e35\u0e1a\u0e33\u0e1a\u0e31\u0e14 Qualitative Quantitative Composition Epoetin alpha 4000 units\/ml Pharmaceutical Dose Form Solution for Injection Dose And Administration \u0e09\u0e35\u0e14\u0e40\u0e02\u0e49\u0e32\u0e2b\u0e25\u0e2d\u0e14\u0e40\u0e25\u0e37\u0e2d\u0e14\u0e14\u0e33 \u0e2b\u0e23\u0e37\u0e2d\u0e40\u0e02\u0e49\u0e32\u0e43\u0e15\u0e49\u0e1c\u0e34\u0e27\u0e2b\u0e19\u0e31\u0e07 50-150 \u0e2b\u0e19\u0e48\u0e27\u0e22\u0e15\u0e48\u0e2d\u0e01\u0e34\u0e42\u0e25\u0e01\u0e23\u0e31\u0e21 \u0e2a\u0e31\u0e1b\u0e14\u0e32\u0e2b\u0e4c\u0e25\u0e30 3 \u0e04\u0e23\u0e31\u0e49\u0e07 Contraindications - \u0e1c\u0e39\u0e49\u0e17\u0e35\u0e48\u0e44\u0e27\u0e15\u0e48\u0e2d\u0e22\u0e32 mammalian cell-derived products- \u0e1c\u0e39\u0e49\u0e17\u0e35\u0e48\u0e44\u0e27\u0e15\u0e48\u0e2d\u0e2d\u0e31\u0e25\u0e1a\u0e39\u0e21\u0e34\u0e19 (\u0e02\u0e2d\u0e07\u0e21\u0e19\u0e38\u0e29\u0e22\u0e4c)- \u0e1c\u0e39\u0e49\u0e17\u0e35\u0e48\u0e40\u0e1b\u0e47\u0e19\u0e04\u0e27\u0e32\u0e21\u0e14\u0e31\u0e19\u0e42\u0e25\u0e2b\u0e34\u0e15\u0e2a\u0e39\u0e07\u0e41\u0e1a\u0e1a\u0e04\u0e27\u0e1a\u0e04\u0e38\u0e21\u0e44\u0e21\u0e48\u0e44\u0e14\u0e49 Special Warnings Precautions - \u0e2b\u0e22\u0e38\u0e14\u0e43\u0e2b\u0e49\u0e22\u0e32\u0e17\u0e31\u0e19\u0e17\u0e35\u0e41\u0e25\u0e30\u0e17\u0e33\u0e01\u0e32\u0e23\u0e17\u0e14\u0e2a\u0e2d\u0e1a erythropoietin antibodies \u0e43\u0e19\u0e1c\u0e39\u0e49\u0e1b\u0e48\u0e27\u0e22\u0e17\u0e35\u0e48\u0e21\u0e35\u0e01\u0e32\u0e23\u0e40\u0e01\u0e34\u0e14 antibody-mediated Pure\u2026","rel":"","context":"In &quot;Great Eastern Drug Co., Ltd.&quot;","block_context":{"text":"Great Eastern Drug Co., Ltd.","link":"https:\/\/score.ccme.or.th\/ccme-wp\/category\/great-eastern-drug-co-ltd\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2024\/01\/Renogen-Packshot-Samart-Suntornsuk.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2024\/01\/Renogen-Packshot-Samart-Suntornsuk.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/score.ccme.or.th\/ccme-wp\/wp-content\/uploads\/2024\/01\/Renogen-Packshot-Samart-Suntornsuk.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"_links":{"self":[{"href":"https:\/\/score.ccme.or.th\/ccme-wp\/wp-json\/wp\/v2\/posts\/288","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/score.ccme.or.th\/ccme-wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/score.ccme.or.th\/ccme-wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/score.ccme.or.th\/ccme-wp\/wp-json\/wp\/v2\/users\/239871753"}],"replies":[{"embeddable":true,"href":"https:\/\/score.ccme.or.th\/ccme-wp\/wp-json\/wp\/v2\/comments?post=288"}],"version-history":[{"count":3,"href":"https:\/\/score.ccme.or.th\/ccme-wp\/wp-json\/wp\/v2\/posts\/288\/revisions"}],"predecessor-version":[{"id":291,"href":"https:\/\/score.ccme.or.th\/ccme-wp\/wp-json\/wp\/v2\/posts\/288\/revisions\/291"}],"wp:attachment":[{"href":"https:\/\/score.ccme.or.th\/ccme-wp\/wp-json\/wp\/v2\/media?parent=288"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/score.ccme.or.th\/ccme-wp\/wp-json\/wp\/v2\/categories?post=288"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/score.ccme.or.th\/ccme-wp\/wp-json\/wp\/v2\/tags?post=288"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}